Karthikeyan Murugesan

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

JCO precision oncology

Journal for immunotherapy of cancer

NPJ precision oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean C Pavlick, Anil Korkut, Jeffery S Ross, Milind M Javle
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean C Pavlick, Anil Korkut, Jeffery S Ross, Milind M Javle
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma. JCO precision oncology 8 (2024)
Leah Stein, Karthikeyan Murugesan, Julie W Reeser, Zachary Risch, Michele R Wing, Anoosha Paruchuri, Eric Samorodnitsky, Emily L Hoskins, Thuy Dao, Amy Smith, Dat Le, Melissa A Babcook, Yi Seok Chang, Matthew R Avenarius, Muhammad Imam, Aharon G Freud, Sameek Roychowdhury
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer. NPJ precision oncology 8 (1) (2024)
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean C Pavlick, Anil Korkut, Jeffery S Ross, Milind M Javle
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma. JCO precision oncology 8 (2024)
Denis Leonardo Fontes Jardim, Karthikeyan Murugesan, Julia A Elvin, Richard S P Huang, Razelle Kurzrock
PD-L1 gene amplification and focality: relationship with protein expression. Journal for immunotherapy of cancer 11 (2) (2023)
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, Julie A Wallace Reeser, Julia F Hopkins, Karthikeyan Murugesan, Zheng Kuang, Raven Vella, Leah Stein, Zachary Risch, Lianbo Yu, Serifat O Adebola, Anoosha Paruchuri, John Carpten, Jad Chahoud, Stephen B Edge, Jill M Kolesar, Martin McCarter, Kenneth G Nepple, Matthew J Reilley, Courtney Scaife, Abhishek Tripathi, Nancy Single, Richard S P Huang, Lee A Albacker, Sameek Roychowdhury
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology 7 (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Danyi Wang, Brian Elenbaas, Karthikeyan Murugesan, Kunal Shah, Meagan Montesion, Ioannis Gounaris, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays. NPJ precision oncology 7 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, Julie A Wallace Reeser, Julia F Hopkins, Karthikeyan Murugesan, Zheng Kuang, Raven Vella, Leah Stein, Zachary Risch, Lianbo Yu, Serifat O Adebola, Anoosha Paruchuri, John Carpten, Jad Chahoud, Stephen B Edge, Jill M Kolesar, Martin McCarter, Kenneth G Nepple, Matthew J Reilley, Courtney Scaife, Abhishek Tripathi, Nancy Single, Richard S P Huang, Lee A Albacker, Sameek Roychowdhury
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology 7 (2023)
Emily L Hoskins, Eric Samorodnitsky, Michele R Wing, Julie A Wallace Reeser, Julia F Hopkins, Karthikeyan Murugesan, Zheng Kuang, Raven Vella, Leah Stein, Zachary Risch, Lianbo Yu, Serifat O Adebola, Anoosha Paruchuri, John Carpten, Jad Chahoud, Stephen B Edge, Jill M Kolesar, Martin McCarter, Kenneth G Nepple, Matthew J Reilley, Courtney Scaife, Abhishek Tripathi, Nancy Single, Richard S P Huang, Lee A Albacker, Sameek Roychowdhury
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO precision oncology 7 (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Jay A Moore, Kuei-Ting Chen, Russell W Madison, Justin Y Newberg, Zoe Fleischmann, Shuoguo Wang, Radwa Sharaf, Karthikeyan Murugesan, Bernard J Fendler, Jason Hughes, Alexa B Schrock, Priti S Hegde, Geoffrey R Oxnard, David Fabrizio, Garrett M Frampton, Emmanuel S Antonarakis, Ethan S Sokol, Dexter X Jin
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response. JCO precision oncology 7 (2023)
Denis Leonardo Fontes Jardim, Karthikeyan Murugesan, Julia A Elvin, Richard S P Huang, Razelle Kurzrock
PD-L1 gene amplification and focality: relationship with protein expression. Journal for immunotherapy of cancer 11 (2) (2023)
Denis Leonardo Fontes Jardim, Karthikeyan Murugesan, Julia A Elvin, Richard S P Huang, Razelle Kurzrock
PD-L1 gene amplification and focality: relationship with protein expression. Journal for immunotherapy of cancer 11 (2) (2023)
Jessica W Chen, Karthikeyan Murugesan, Justin Y Newberg, Ethan S Sokol, Heidi M Savage, Thomas J Stout, Sophia L Maund, Katherine E Hutchinson
Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations. JCO precision oncology 6 (2022)
Karthikeyan Murugesan, Dexter X Jin, Leah A Comment, David Fabrizio, Priti S Hegde, Julia A Elvin, Brian Alexander, Mia A Levy, Garrett M Frampton, Meagan Montesion, Sameek Roychowdhury, Razelle Kurzrock, Jeffrey S Ross, Lee A Albacker, Richard S P Huang
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer. The oncologist 27 (9) (2022)
Craig Furman, Xiaoling Puyang, Zhaojie Zhang, Zhenhua J Wu, Deepti Banka, Kiran B Aithal, Lee A Albacker, Ming-Hong Hao, Sean Irwin, Amy Kim, Meagan Montesion, Alyssa D Moriarty, Karthikeyan Murugesan, Tuong-Vi Nguyen, Victoria Rimkunas, Tarek Sahmoud, Michael J Wick, Shihua Yao, Xun Zhang, Hao Zeng, Frédéric H Vaillancourt, David M Bolduc, Nicholas Larsen, Guo Zhu Zheng, Sudeep Prajapati, Ping Zhu, Manav Korpal
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer. Molecular cancer therapeutics 21 (6) (2022)
Smruthy S Sivakumar, Dexter X Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Natalie Danziger, Dean Pavlick, Ole Gjoerup, Jeffrey S Ross, Robert Harmon, Jon Chung, Brennan Decker, Lucas Dennis, Garrett M Frampton, Luciana Molinero, Steffi Oesterreich, Jeffrey M Venstrom, Geoffrey R Oxnard, Priti S Hegde, Ethan S Sokol
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer. Nature communications 13 (1) (2022)
Andrew D Kelly, Karthikeyan Murugesan, Zheng Kuang, Meagan Montesion, Jeffrey S Ross, Lee A Albacker, Richard S P Huang, Douglas I Lin, Umut Demirci, James Creeden
Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response. Journal for immunotherapy of cancer 9 (11) (2021)
Meagan Montesion, Karthikeyan Murugesan, Dexter X Jin, Radwa Sharaf, Nora Sanchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S Sokol, Dean C Pavlick, Jay A Moore, Alan Braly, Gaurav Singal, David Fabrizio, Leah A Comment, Naiyer A Rizvi, Brian M Alexander, Garrett M Frampton, Priti S Hegde, Lee A Albacker
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response. Cancer discovery 11 (2) (2020)